Impact of the 13-valent pneumococcal conjugate vaccine (PCV13) on acute mastoiditis in children in southern Israel: A 12-year retrospective comparative study (2005–2016)

To define the trends in acute mastoiditis (AM) incidence, microbiology, complications and management in children, before and after the 13-valent pneumococcal conjugate vaccine (PVC13) introduction. Medical records of all AM patients

Saved in:
Bibliographic Details
Published in:International journal of pediatric otorhinolaryngology 2021-01, Vol.140, p.110485-110485, Article 110485
Main Authors: Sapir, Aviad, Ziv, Oren, Leibovitz, Eugene, Kordeluk, Sophia, Rinott, Ehud, El-Saied, Sabri, Greenberg, David, Kaplan, Daniel M.
Format: Article
Language:English
Subjects:
Children
Mastoiditis
PCV13
Serotypes
Streptococcus pneumoniae
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To define the trends in acute mastoiditis (AM) incidence, microbiology, complications and management in children, before and after the 13-valent pneumococcal conjugate vaccine (PVC13) introduction. Medical records of all AM patients
ISSN:0165-5876
1872-8464
DOI:10.1016/j.ijporl.2020.110485